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Purpose: Aging has severe implications for tissue damage and is a major risk factor for disease.
However, the effects of aging on cardiac extracellular matrix (ECM) components in individuals
free of cardiovascular disease are incompletely understood. We aimed at the characterization
of the effects of aging on major ECM proteins in the heart of men and women.
Experimental design: Left ventricular (LV) samples of nondiseased human hearts technically
unusable for transplantation obtained from general organ donors (n = 31; age 17–68 years;
48% women) were used for protein isolation. We separated the group into 17–40 years (n = 7
men and 7 women) and 50–68 years (n = 9 men and 8 women).
Results: Analysis of ECM proteins demonstrated an age-dependent sex-specific regulation of
collagen type I and III (interaction p < 0.05), type VI (interaction p = 0.01), tissue inhibitor
of metalloproteinase 3 (interaction p < 0.05), SMAD2 (interaction p < 0.05), and SMAD3
(interaction p = 0.001). Overall, the levels of these proteins in younger individuals were lower
in women than men, while in older individuals they were higher in women than men.
Conclusions and clinical relevance: This age-mediated myocardial ECM remodeling might
play a key role in the limited ability of the aging heart to adapt adequately to altered work load
and to respond to tissue damage. Therapeutic agents that target ECM homeostasis represent
promising prevention strategies.
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1 Introduction
Aging is one of the major risk factors for disease. It fa-
vors tissue damage, while it hinders tissue repair. Homeo-
static imbalance is an important hallmark of aging. In the
heart, aging is characterized by a progressive alteration of
myocardial structure and is a risk factor for cardiac morbid-
ity and mortality [1]. Age-dependent myocardial remodeling
is, among others, related with changes in the amount and
organization of extracellular matrix (ECM) components [2].
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In fact, the process of aging in the heart is associated with
a loss of cardiomyocytes and subsequent hypertrophy of the
remaining cells, which, in turn, may lead to alterations in
ECM composition.
The myocardial ECM is mainly composed of fibrillar col-
lagens, i.e. types I and III. Collagen degradation is medi-
ated by matrix metalloproteinases (MMP). MMP activity is,
in turn, inhibited by tissue-specific inhibitors of metallo-
proteinases (TIMP) [3]. An important factor for the main-
tenance of ECM integrity and stability is the transforming
growth factor (TGF). In fact, activation of the TGF signal-
ing pathway may induce factors with potent fibrogenic ac-
tions, such as periostin. The downstream effectors of TGF
are the SMAD family member proteins, which, when phos-
phorylated, translocate to the nucleus, and activate gene tran-
scription [4]. Structural proteins of the ECM, such as vimentin
and vinculin, play a primary role in tissue architecture provid-
ing structural support and tissue organization. Furthermore,
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Clinical Relevance
Aging is a physiological process that also affects the
heart with striking impact on clinical outcomes in
healthy elderly individuals and in patients with car-
diovascular disease. The interaction between age-
induced functional and structural changes and the
actual mechanisms of disease will define the prog-
nosis and severity of cardiovascular disease occur-
rence in aging populations. Myocardial remodeling
due to alterations in extracellular matrix (ECM) com-
ponents leads to cardiac dysfunction representing a
major clinical burden. However, the role of aging in
this process in men and women is not completely
understood. The present study provides evidence of
changes in ECM that may increase vulnerability of
the human heart to tissue damage, thereby under-
lying the onset of age-related cardiac disease. Fur-
ther knowledge on age-dependent alterations of the
ECM will give rise to novel perspectives with diag-
nostic and therapeutic potential. Subsequently, the
development of strategies targeting these factors is
of clinical relevance.
ECM components mediate transduction of cell survival sig-
nals promoting tissue repair pathways, thereby maintaining
function [5].
Aberrant induction of ECM components can initiate a cas-
cade of events, including the activation of signal transduction
pathways, which, in turn, activate cellular responses that may
promote tissue damage [6]. The balance of ECM synthesis
and degradation is essential for normal cardiac structure and
function. The disruption of ECM homeostasis is a key factor
for the progression of cardiac dysfunction [7]. Thus, a better
understanding of the modulation of ECM regulatory compo-
nents with aging is necessary for gaining novel insight into
managing age-related cardiac tissue damage and dysfunction.
To this extent, significant age-related changes in myocar-
dial ECM components, particularly higher left ventricular
(LV) collagen content, have been reported in aged rats com-
pared to young rats [8–10], mice [11–16], and in sheep [17].
However, how aging affects the myocardial ECM in humans
is not fully understood. In the present study, we aimed at the
characterization of the effects of aging on major ECM pro-
teins in the human heart hypothesizing differences between
men and women.
2 Materials and methods
2.1 Collection of left ventricular tissues
Samples from the lateral LV wall of nondiseased human
hearts technically unusable for transplantation obtained from
general organ donors (n = 31; 48% women) were frozen im-
mediately in liquid nitrogen until further processing. In par-
ticular, we divided our samples into two age groups, i.e. 17–
40 years (n = 7 men and 7 women) and 50–68 years (n = 9
men and 8 women). We excluded the age group 40–50 years to
avoid the peri-menopausal phase of female individuals with
highly irregular levels of sex hormones, particularly estro-
gens. Experimental protocols were approved by the Scientific
and Research Ethical Committee of the Medical Scientific
Board at the Hungarian Ministry of Health (ETT-TUKEB:
4991-0/2010-1018EKU), followed the principles outlined in
the Declaration of Helsinki and written consent was obtained
from all donors.
2.2 Protein extraction and immunoblotting
LV samples were homogenized in a modified RIPA buffer
(50 mM Tris-HCl, pH 7.4, 150 mM NaCl, 1 mM EDTA,
1% NP-40, 0.25% Na-deoxycholate) supplemented with pro-
tease inhibitor cocktail (Roche, Mannheim, Germany) and
the phosphatase inhibitors sodium orthovanadate (1 mM
Na3VO4) and sodium fluoride (1 mM NaF). Proteins were
quantified using the BCA Assay (Thermo Scientific Pierce
Protein Biology, Schwerte, Germany), resolved by SDS-
PAGE, transferred to nitrocellulose membranes using stan-
dard procedures. Membranes were probed with primary an-
tibodies: collagen 1A2 (M-80, Santa Cruz, Dallas, TX, USA),
collagen 3A1 (H-300, Santa Cruz, Dallas, TX, USA), colla-
gen 6A1 (H-200, Santa Cruz, Dallas, TX, USA), MMP2 (Cell
Signaling, Danvers, MA, USA), MMP9 (abcam, Cambridge,
UK), TIMP1 (H-150, Santa Cruz, Dallas, TX, USA), TIMP3
(H-55, Santa Cruz, Dallas, TX, USA), periostin (S-15, Santa
Cruz, Dallas, TX, USA), TGF1 (Santa Cruz, Dallas, TX,
USA), SMAD2 (Cell Signaling, Danvers, MA, USA), SMAD3
(Cell Signaling, Danvers, MA, USA), p-SMAD2 (Cell Signal-
ing, Danvers, MA, USA), p-SMAD3 (Cell Signaling, Danvers,
MA, USA), SMAD4 (Cell Signaling, Danvers, MA, USA), vi-
mentin (Sigma, Germany), vinculin (Sigma, Germany), and
HSP60 (Enzo, USA) serving as loading control. Immunoreac-
tive proteins were detected using ECL Plus (GE Healthcare,
Buckinghamshire, UK) and quantified by the ImageJ 1.41
version software (http://rsbweb.nih.gov/ij/).
2.3 Histology
Frozen LV tissue samples were cut into 5 m sections and
stained with picro-sirius red staining for collagen content
using standard procedures as described previously [18, 19].
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2.4 Statistical analysis
Data are shown as mean ± SEM. Comparisons among mul-
tiple groups were performed using 2-way ANOVA, which
assesses the effect of two different categorical independent
variables on one continuous dependent variable. This statis-
tical test assesses the main effect of each independent variable
alone, as well as if there is any interaction between these two
independent variables. In other words, with 2-way ANOVA
the effects of aging and sex alone, as well as the interaction
of both factors on ECM protein abundance were assessed.
Tukey’s post-hoc test was used to adjust for multiple pairwise
comparisons. All tests were performed with the R version
2.14.2 software considering p  0.05 significant.
3 Results
3.1 Study design
To study the effects of aging on major ECM proteins of the
human myocardium, we collected LV samples of male and
female donors (n = 31) with no apparent cardiovascular dis-
ease. We separated the group into younger (17–40 years; n =
7 male and 7 female) and older (50–68 years; n = 9 male and
8 female) individuals. Therefore, the present study design of-
fered the possibility to perform an integrative investigation of
the effects of aging, sex, and the interaction of both factors on
ECM protein abundance. We focused our efforts on proteins
with a known and major role in ECM homeostasis, remod-
eling, and the regulation thereof, such as collagens, MMPs
and TIMPs. We also assessed proteins of the TGF signaling
pathway, which is an important player in the pathogenesis
of cardiac remodeling and fibrosis, as well as two proteins
necessary for cytoskeletal integrity and structural adaptation.
3.2 Collagens
Collagens are the main component of myocardial ECM, with
collagen types I and III being the most abundant ECM pro-
teins, and are essential for cardiac structure and function.
The levels of collagen type I (COL1A2) and III (COL3A1)
were modulated by aging in a sex-specific manner (interac-
tion p < 0.05; Fig. 1). In younger individuals, women had
less collagen types I and III than men, while in older indi-
viduals, women had more collagen types I and III than men.
In addition, aging alone led to significantly increased levels
of collagen type III in older women compared to younger
women (adjusted p < 0.05; Fig. 1B).
Similarly, the levels of collagen type VI (COL6A1) were
modulated by aging in a sex-specific manner (interaction p =
0.01; Fig. 1B). In younger individuals, women had less colla-
gen type VI than men, while in older individuals, women
had more collagen type VI than men. In this case, the
difference between younger men and younger women
showed a statistical trend (adjusted p < 0.1).
Figure 1. Effects of aging, sex, or the interaction of both factors
on collagens. Collagen type I (COL1A2) and III (COL3A1) were
modulated by aging in a sex-specific manner (interaction p <
0.05). Similarly, collagen type VI (COL6A1) levels were modu-
lated by aging in a sex-specific manner (interaction p = 0.01).
Older women had significantly increased levels of collagen type
III compared with younger women (adjusted p < 0.05). In all fig-
ures: representative images of immunoblotting analysis with an-
tibodies specific for the indicated proteins in left ventricular tis-
sue samples from younger (17–40 years) and older (50–68 years)
men and women are shown; the lanes were run on the same
gel but were noncontiguous; HSP60 served as loading control;
semiquantification of protein profiling by means of densitometry
analysis is shown; data present mean ± SEM; the top p value
is used to indicate the effect of the interaction of aging and sex;
n = 7 younger male; n = 7 younger female; n = 9 older male;
n = 8 older female.
3.3 Matrix metalloproteinases
MMPs initiate and degrade collagens and are involved in
the decomposition of collagen degradation products. The
levels of MMP2 and MMP9 were not significantly changed
(Fig. 2A and B). However, a statistical trend was found in the
levels of MMP9 due to the interaction between aging and sex
(interaction p < 0.1; Fig. 2B).
3.4 Tissue inhibitor of metalloproteinases
TIMPs are the major inhibitors of MMPs and therefore
involved in ECM remodeling. The levels of TIMP3 were
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Figure 2. Effects of aging, sex, or the interaction of both factors
on matrix metalloproteinases and tissue inhibitor of metallopro-
teinases. There was no significant change of MMP2 (A) and MMP9
(B) proteins. TIMP3 (C) was modulated by aging in a sex-specific
manner (interaction p < 0.05). There was no significant change
of TIMP1 (C). TIMP2 (D) levels were significantly higher in older
women than in older men (adjusted p < 0.05), younger women
(adjusted p < 0.05), and younger men (adjusted p = 0.01).
modulated by aging in a sex-specific manner (interaction
p < 0.05; Fig. 2C). In younger individuals, women had less
TIMP3 than men, while in older individuals, women had
more TIMP3 than men.
A similar regulation was found for TIMP1. However, the
interaction between aging and sex showed a statistical trend
(interaction p < 0.1; Fig. 2C).
On the other hand, the levels of TIMP2 were significantly
higher in older women than in older men (adjusted p <
0.05), younger women (adjusted p < 0.05), and younger men
(adjusted p = 0.01; Fig. 2D).
3.5 Transforming growth factor  signaling proteins
TGF and its downstream effectors the SMAD proteins are
involved in cardiac remodeling by regulating ECM gene ex-
pression. The levels of TGF were significantly lower in
younger individuals than in older individuals (p = 0.05;
Fig. 3A). There was no further statistically significant effect
or trend on this protein.
The levels of SMAD2 were modulated by aging in a sex-
specific manner (interaction p < 0.05; Fig. 3B). In younger
individuals, women had less SMAD2 than men, while in older
individuals, women had more SMAD2 than men. Notably,
older women had significantly more SMAD2 than older men
(adjusted p = 0.01) and younger women (adjusted p = 0.05;
Fig. 3B). However, there was no statistical significance or
trend for the levels of phosphorylated SMAD2 related to total
SMAD2.
Similarly, the levels of SMAD3 were also modulated by ag-
ing in a sex-specific manner (interaction p = 0.001; Fig. 3C).
In younger individuals, women had less SMAD3 than men,
while in older individuals, women had more SMAD3 than
men. Notably, older women had significantly more SMAD3
than older men (adjusted p < 0.05) and younger women
(adjusted p < 0.05; Fig. 3C). Furthermore, the levels of phos-
phorylated SMAD3 related to total SMAD3 were significantly
higher in older women than in older men (adjusted p < 0.05;
Fig. 3C).
Significant effects on the levels of SMAD4 were found due
to aging (p < 0.001) and sex (p = 0.01), and the interaction of
both factors had a strong statistical trend (p = 0.06). Notably,
older women had significantly more SMAD4 than older men
(adjusted p < 0.05), younger men (adjusted p < 0.001), and
younger women (adjusted p < 0.01; Fig. 3D).
3.6 Cytoskeletal proteins
Vimentin and vinculin are important proteins of the cy-
toskeleton necessary for the maintenance of cardiac structure
and function. The levels of vimentin were significantly higher
in younger individuals than in older individuals (p < 0.001;
Fig. 4A). In addition, there was a significant effect of the in-
teraction between aging and sex (interaction p = 0.01). In
younger individuals, women had more vimentin than men,
while in older individuals, women had less vimentin than
men. Notably, older women had significantly less vimentin
than older men (adjusted p = 0.05) and younger women (ad-
justed p < 0.001; Fig. 4A).
The levels of vinculin showed a statistical trend due to
the interaction between aging and sex (interaction p < 0.1;
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Figure 3. Effects of aging, sex, or the interaction of both factors
on TGF1 and SMAD proteins. Levels of TGF1 (A) were signifi-
cantly lower in younger individuals than in older individuals (p =
0.05). SMAD2 (B) was modulated by aging in a sex-specific man-
ner (interaction p < 0.05). Older women had significantly more
SMAD2 than older men (adjusted p = 0.01) and younger women
(adjusted p = 0.05). SMAD3 (C) was also modulated by aging
in a sex-specific manner (interaction p = 0.001). Notably, older
women had significantly more SMAD3 than older men (adjusted
p < 0.05) and younger women (adjusted p < 0.05). The levels of
phosphorylated SMAD3 were significantly higher in older women
than in older men (adjusted p < 0.05). SMAD4 (D) was signifi-
cantly higher in older women compared with older men (adjusted
p < 0.05), younger men (adjusted p < 0.001), and younger women
(adjusted p < 0.01).
Figure 4. Effects of aging, sex, or the interaction of both factors
on vimentin (A) and vinculin (B). Vimentin was modulated by
aging in a sex-specific manner (interaction p = 0.01). Addition-
ally, vimentin levels were significantly higher in younger individ-
uals compared with older individuals (p < 0.001). Notably, older
women had significantly less vimentin than older men (adjusted
p = 0.05) and younger women (adjusted p < 0.001). On the other
hand, vinculin protein levels were not significantly changed.
Fig. 4B). This trend revealed that in younger individuals,
women had more vinculin than men, while in older indi-
viduals, women had less vinculin than men.
3.7 Matricellular protein periostin
Periostin is a matricellular protein associated with cardiac
collagen deposition exerting potent fibrogenic actions. There
was no statistically significant effect or trend on the levels of
periostin (Fig. 5).
3.8 Histological analysis of collagen content
To further assess the effects of aging on ECM homeostasis
in the human heart, we performed picro-sirius red staining
to quantify morphometric analysis of collagen content in his-
tological sections. There was no statistically significant effect
or trend on collagen content (Fig. 6).
4 Discussion
In the current study, we present data on the effects of aging
on major ECM components in hearts of men and women.
Our findings provide insight into potential age-dependent
mechanisms that might contribute to increased vulnerabil-
ity of the human heart to tissue damage. In particular, we
found that the protein levels of collagen types I, III, and VI,
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Figure 5. Effects of aging, sex, or the interaction of both fac-
tors on periostin. Periostin protein levels were not significantly
changed in left ventricular tissue samples from younger and older
men and women.
Figure 6. Effects of aging, sex, or the interaction of both fac-
tors on collagen content assessed histologically. Representative
picro-sirius red staining images and quantification of collagen
content in histological sections of left ventricular samples from
younger and older men and women. There was no significant
change of the heart collagen content detected. Data present
mean ± SEM. Scale bar: 200 m; n = 5/group.
TIMP3, SMAD2, and SMAD3 were lower in women than
men in younger individuals, while in older individuals they
were higher in women than men.
Several studies employing rodents have shown significant
increases in myocardial ECM components with aging [8–
12]. Furthermore, a study combining electron microscopy
and histochemical analysis of human hearts revealed that
collagen types I and III increase in number and thickness
as a function of age [20]. However, the effects of aging on
myocardial ECM protein levels in men and women free of
cardiovascular disease are not fully understood. To this extent,
we found a generalized tendency toward an induction of ECM
components in the hearts of older women.
The myocardium is susceptible to tissue damage triggered
by several factors, such as ischemic injury, excessive inflam-
mation, and aberrantly altered work load. Due to limited
cardiac tissue regenerative capacity, tissue repair is mainly
mediated through the modulation of the myocardial ECM,
especially collagens [21]. As a result, collagen synthesis and
degradation dysregulation favors interstitial and perivascular
collagen deposition, leading to increased myocardial stiffness
and cardiac dysfunction [22]. Consequently, during cardiac
senescence, induction of ECM proteins may play a role in
the maintenance of the structural integrity of the heart, but
on the other hand it may be involved in the pathogenesis of
age-related fibrosis.
In particular, excessive deposition and cross-linking of
ECM components in the myocardium play an important role
in the pathogenesis of diastolic heart failure, i.e. heart fail-
ure with preserved ejection fraction, in aging hearts [23, 24],
and may lead to arrhythmias [25]. This age-related increase of
fibrillar collagen content and myocardial diastolic stiffness ap-
pears to be dependent on mechanisms regulating the process-
ing of newly synthesized procollagen into mature collagen fib-
rils [13]. Notably, exercise training was shown to protect the
aging heart against dysregulation of MMPs and fibrosis by
suppressing elevation of TIMP1 and TGF [26]. Women suf-
fer more commonly from diastolic heart failure than men [27].
Women are also more susceptible to drug-induced QT prolon-
gation, torsades de pointes, and paroxysmal supraventricular
tachycardia [28–31]. Therefore, the coordinated increase in
collagen and TIMP protein levels we identified in the aging fe-
male myocardium might contribute to the higher incidence of
diastolic dysfunction in women and might predispose them to
arrhythmias.
The mechanisms responsible for the age-dependent in-
creases in myocardial ECM components are unclear. ECM
homeostasis and collagen content in the myocardium could
be due to the regulation of collagen and other factors at the
transcriptional level. It is likely that the regulatory elements
involved in this process may include steroid hormones, as
some of the genes coding for these proteins have putative
full or half-site steroid response elements in their sequences.
Nevertheless, they have even been shown to be under the
regulation of steroid hormones without the involvement of
steroid response elements [32–34]. In fact, aging has been
associated with changes in sex steroid hormones, particularly
17-estradiol (E2), increased cardiac tissue damage and risk
for cardiovascular disease. In previous studies, we have found
that E2 exerts direct effects in the heart that maybe sex specific
[35–40]. Notably, treatment of fibroblasts with E2 led to in-
creased gene expression of collagen types I and III in males
but to decreased levels of these genes in females [34]. Fur-
thermore, E2 led to decreased MMP2 gene levels [32]. These
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findings indicate that the presence of E2 is necessary for
the repression of ECM components in the female heart. On
the basis of this, considering that the older women included
in this study are most likely postmenopausal, the decreased
levels of circulatory E2 might contribute to the increases in
myocardial ECM components in this group.
In addition, it has to be noted that these increasing levels
are not of the same degree as we have found previously for
ECM and particularly fibrosis markers under diseased condi-
tions, where male hearts show significantly higher levels than
female hearts [41, 42]. Besides, periostin, a mediator of fibro-
sis [43, 44], did not show any statistical regulation or trend
also indicating that the age-related increase in ECM compo-
nents in women is not of pathological nature. The SMAD pro-
teins are the downstream effectors of TGF. When SMAD2
and SMAD3 are phosphorylated, they bind to SMAD4 and
translocate to the nucleus, where they activate gene tran-
scription of profibrotic factors. In fact, it has been shown that
the pSMAD3-SMAD4 complex mediates early ECM compo-
nent regulation, while the pSMAD2-SMAD4 complex is re-
sponsible for long-term/persistent regulation processes [45].
Therefore, the higher levels of pSMAD3 and SMAD4 in older
women compared to age-matched men in the absence of any
differences in pSMAD2 levels also indicate a nonpathological
regulation of myocardial ECM components in older women.
Collectively, these findings indicate that aging alone in the
female heart did not lead to the conversion of fibroblasts to
myofibroblasts.
Our study was constrained by a relatively small sample
size stratified by sex and high heterogeneity related to human
biological material. Due to this, statistical significance might
have not been reached in cases of a pronounced trend for
sex differences. Furthermore, information on endogenous
circulating hormones or exogenous administration of hor-
mones was missing. We have also not established a connec-
tion between ECM and fibroblast numbers. This is certainly
an exciting point for further investigation under appropriate
experimental approaches, such as measurements of isolated
fibroblasts from fresh cardiac tissues.
In summary, our study shows how aging affects major
ECM proteins in the heart of men and women. The age-
dependent alterations in myocardial ECM components are
expected to favor ECM accumulation and may contribute to
mechanisms increasing the vulnerability of the heart to tissue
damage.
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